The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies

C Lam, JY Low, PT Tran, H Wang - Cancer letters, 2021 - Elsevier
The hexosamine biosynthetic pathway (HBP) is a glucose metabolism pathway that results
in the synthesis of a nucleotide sugar UDP-GlcNAc, which is subsequently used for the post …

O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy

Q Lu, X Zhang, T Liang, X Bai - Molecular Medicine, 2022 - Springer
O-linked β-dN-acetylglucosamine (O-GlcNAc) is an important post-translational modification
of serine or threonine residues on thousands of proteins in the nucleus and cytoplasm of all …

O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit

M Jiang, B Xu, X Li, Y Shang, Y Chu, W Wang, D Chen… - Oncogene, 2019 - nature.com
Advanced colorectal cancer (CRC) is one of the deadliest cancers, and the 5-year survival
rate of patients with metastasis is extremely low. The epithelial–mesenchymal transition …

O-GlcNAcylation in cancer development and immunotherapy

XF He, X Hu, GJ Wen, Z Wang, WJ Lin - Cancer Letters, 2023 - Elsevier
O-linked β-DN-acetylglucosamine (O-GlcNAc), as a posttranslational modification (PTM), is
a reversible reaction that attaches β-N-GlcNAc to Ser/Thr residues on specific proteins by O …

A conserved splicing silencer dynamically regulates O-GlcNAc transferase intron retention and O-GlcNAc homeostasis

SK Park, X Zhou, KE Pendleton, OV Hunter, JJ Kohler… - Cell reports, 2017 - cell.com
Modification of nucleocytoplasmic proteins with O-GlcNAc regulates a wide variety of cellular
processes and has been linked to human diseases. The enzymes O-GlcNAc transferase …

[HTML][HTML] Drug resistance related to aberrant glycosylation in colorectal cancer

N Very, T Lefebvre, I El Yazidi-Belkoura - Oncotarget, 2018 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the fourth leading cause of cancer-related deaths in the world.
Drug resistance of tumour cells remains the main challenge toward curative treatments …

Glutamine deprivation triggers NAGK-dependent hexosamine salvage

S Campbell, C Mesaros, L Izzo, H Affronti, M Noji… - Elife, 2021 - elifesciences.org
Tumors frequently exhibit aberrant glycosylation, which can impact cancer progression and
therapeutic responses. The hexosamine biosynthesis pathway (HBP) produces uridine …

Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells

S Raab, A Gadault, N Very, A Decourcelle… - Cellular and Molecular …, 2021 - Springer
Fatty acid synthase (FASN) participates in many fundamental biological processes,
including energy storage and signal transduction, and is overexpressed in many cancer …

Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer

N Very, S Hardivillé, A Decourcelle, J Thévenet… - Oncogene, 2022 - nature.com
Alteration of O-GlcNAcylation, a dynamic posttranslational modification, is associated with
tumorigenesis and tumor progression. Its role in chemotherapy response is poorly …

The role of glycosyltransferases in colorectal cancer

C Fernández-Ponce, N Geribaldi-Doldán… - International journal of …, 2021 - mdpi.com
Colorectal cancer (CRC) is one of the main causes of cancer death in the world. Post-
translational modifications (PTMs) have been extensively studied in malignancies due to its …